![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
1. 2224-52-4
2. (s)-4-methyl-2,5-oxazolidinedione
3. (4s)-4-methyl-1,3-oxazolidine-2,5-dione
4. (4s)-4-methyloxazolidine-2,5-dione
5. N-carboxyalanine Anhydride
6. Mfcd03411276
7. 2,5-oxazolidinedione, 4-methyl-, (s)-
8. Einecs 218-750-4
9. Schembl6230697
10. Dtxsid70176781
11. Dtetycnjkauroo-reohclbhsa-n
12. (4s)-4-methyl-2,5-oxazolidinedione
13. (s)-4-methyl-2, 5-oxazolidinedione
14. Akos006276101
15. Am84795
16. Ds-4192
17. Cs-0158166
18. A851146
Molecular Weight | 115.09 g/mol |
---|---|
Molecular Formula | C4H5NO3 |
XLogP3 | -0.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 0 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 55.4 |
Heavy Atom Count | 8 |
Formal Charge | 0 |
Complexity | 142 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.